Final Class II Order, Special Controls For Hemoglobin A1c Tests Set
This article was originally published in The Gray Sheet
Executive Summary
FDA spells out the special controls needed for class II specification of hemoglobin A1c test systems in a final order taking effect Sept. 24.
You may also be interested in...
New Products In Brief
Bausch & Lomb gets approval for first-of-a-kind intraocular lens. Roche HbA1c assay is first to be cleared to diagnose diabetes. More product launches and approvals from the past week.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.